Leadership Transition at the Duke Human Vaccine Institute
After nearly four decades, Barton Haynes, MD, has decided to step down as director of the Duke Human Vaccine Institute (DHVI).
Wilton Williams receives faculty research prize
Wilton Williams, PhD, an associate professor in surgery and DHVI member, has been named a recipient of the Ruth and A. Morris Williams Faculty Research Prize.
Locking Viruses Out: A New Approach to Infection Prevention
Nicholas Heaton, PhD, professor of molecular genetics and microbiology, is looking at host-targeted treatments for viral infections.
Nicholas Heaton Awarded Distinguished Professorship
Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.
The DNA repair duo cancers use to build ecDNA — and gain an advantage
Duke University School of Medicine researchers, led by DHVI affiliate Zhao Zhang, PhD, have discovered the keys to survival for a circular form of DNA that drives many aggressive cancers.
Institute Director Bart Haynes honored for 45 years of Duke service
On March 9, members of the Duke Human Vaccine Institute (DHVI) gathered virtually for the annual DHVI Service & Core Values Awards Ceremony to celebrate
Avoiding Viral Illness During the Holidays
Two Duke Health physicians, including DHVI affiliate Cameron Wolfe, MBBS, say vaccines will go a long way towards helping people weather the spikes in disease during the winter. So will the other traditional methods we learned during the pandemic: Stay home if you’re sick and wear a mask if you’re in a crowd.
Avoiding Viral Illness During the Holidays
Two Duke Health physicians, including DHVI affiliate Cameron Wolfe, MBBS, share advice to help people weather the spikes in disease during the winter.
10 groundbreaking advances that grew out of HIV research
A new Nature Medicine paper highlights how 40 years of HIV research reshaped far more than the fight against one virus. What began as an urgent global health response helped fuel breakthroughs that now power treatments for cancer, tuberculosis, hepatitis, and even COVID-19 — thanks to sustained U.S. investment and collaboration across universities, industry, and government.
Georgia Tomaras Receives 2025 Faculty Award
DHVI member Georgia Tomaras, PhD, the A. Geller Distinguished Professor for Research in Immunology received a Research Mentoring Award, which recognizes excellence in mentoring across clinical, translational, population health, and basic sciences. She was honored for career mentoring in basic science.